scholarly journals The Genetics of Sudden Infant Death Syndrome—Towards a Gene Reference Resource

Genes ◽  
2021 ◽  
Vol 12 (2) ◽  
pp. 216
Author(s):  
Emma B. Johannsen ◽  
Linda B. Baughn ◽  
Neeraj Sharma ◽  
Nicolina Zjacic ◽  
Mehdi Pirooznia ◽  
...  

Sudden infant death syndrome (SIDS) is the unexpected death of an infant under one year of age that remains unexplained after a thorough investigation. Despite SIDS remaining a diagnosis of exclusion with an unexplained etiology, it is widely accepted that SIDS can be caused by environmental and/or biological factors, with multiple underlying candidate genes. However, the lack of biomarkers raises questions as to why genetic studies on SIDS to date are unable to provide a clearer understanding of the disease etiology. We sought to improve the identification of SIDS-associated genes by reviewing the SIDS genetic literature and objectively categorizing and scoring the reported genes based on the strength of evidence (from C1 (high) to C5 (low)). This was followed by analyses of function, associations between genes, the enrichment of gene ontology (GO) terms, and pathways and gender difference in tissue gene expression. We constructed a curated database for SIDS gene candidates consisting of 109 genes, 14 of which received a category 4 (C4) and 95 genes received the lowest category of C5. That none of the genes was classified into the higher categories indicates the low level of supporting evidence. We found that genes of both scoring categories show distinct networks and are highly diverse in function and involved in many GO terms and pathways, in agreement with the perception of SIDS as a heterogeneous syndrome. Genes of both scoring categories are part of the cardiac system, muscle, and ion channels, whereas immune-related functions showed enrichment for C4 genes. A limited association was found with neural development. Overall, inconsistent reports and missing metadata contribute to the ambiguity of genetic studies. Considering those parameters could help improve the identification of at-risk SIDS genes. However, the field is still far from offering a full-pledged genetic test to identify at-risk infants and is still hampered with methodological challenges and misunderstandings of the vulnerabilities of vital biological mechanisms.

PEDIATRICS ◽  
1973 ◽  
Vol 51 (4) ◽  
pp. 755-755
Author(s):  
David S. Bachman

The article on prolonged apnea and the sudden infant death syndrome (SIDS) by Steinschneider1 is very exciting in that it suggests the possibility of identifying infants at risk from SIDS before the final event. Obviously, it is of great importance to learn the mechanism causing the preceding apneic episodes. Do they represent vagal overactivity? Stimulation of the intact vagus nerve in the unanesthetized monkey causes apnea, as well as bradycardia and even arrhythmias.2 In fact, we have seen myocardial myocytolysis secondary to vagal stimulation.3


1995 ◽  
Vol 127 (3) ◽  
pp. 384-388 ◽  
Author(s):  
Jean M. Silvestri ◽  
David R. Hufford ◽  
Jane Durham ◽  
Sheilah M. Pearsall ◽  
Mary Ann Oess ◽  
...  

1991 ◽  
Vol 36 (s1) ◽  
pp. 434-435 ◽  
Author(s):  
Gerhard Litscher ◽  
Gert Pfurtscheller ◽  
Karlheinz Matuschik ◽  
Dieter Gergen ◽  
Reinhard Haidmayer ◽  
...  

1996 ◽  
Vol 39 ◽  
pp. 113-113 ◽  
Author(s):  
Jean M Silvestri ◽  
Michael J Corwin ◽  
Larry Tinsley ◽  
Tom G Keens ◽  
Carl E Hunt ◽  
...  

PEDIATRICS ◽  
1978 ◽  
Vol 61 (4) ◽  
pp. 664-665
Author(s):  
Ann R. Stark ◽  
Frederick Mandell ◽  
H. William Taeusch

The use of apnea monitors at home to prevent sudden infant death syndrome (SIDS) in infants at risk is a debated issue. Several very difficult questions await answers: (1) Who should be monitored? (2) What kinds of monitors would be most effective? (3) Does monitoring work? (4) Are other approaches apt to be simpler and more efficacious, e.g., respiratory stimulants? What is known about SIDS is mostly epidemiologic information. The incidence is 2 to 3 per 1,000 live births, with a peak age distribution between 2 and 4 months. Most deaths are silent and occur when the infant is supposedly asleep.


PEDIATRICS ◽  
1986 ◽  
Vol 77 (6) ◽  
pp. 807-810 ◽  
Author(s):  
Yvan Vandenplas ◽  
D. De Wolf ◽  
L. Sacre

Theophylline and caffeine are two drugs frequently administered to infants at risk for sudden infant death syndrome, because of their stimulatory effects on the respiratory system. These drugs are known to increase gastric acid secretion and to decrease lower esophageal sphincter pressure that, in turn, possibly increases gastroesophageal reflux (GER). Thirty babies were tested for GER before and during caffeine treatment. Eighteen were studied under the same conditions while undergoing theophylline treatment. All results of pH monitoring before treatment were within normal ranges. Episodes of GER increased significantly (P < .001) in about 50% of the group treated with caffeine and in 66% of the group treated with theophylline. These results were independent of plasma xanthine concentrations (within or below therapeutic ranges) and of the efficacy of the drug. In addition, an increase was noted for the number of episodes of GER in 24 hours (from 5.3 to 17.1 in the caffeine group and from 5.3 to 24.3 in the theophylline group) and for the time pH was < 4 (from 0.87% to 6% in the caffeine group and up to 13% in the theophylline group). Because GER is another known risk factor for sudden infant death syndrome, the administration xanthine derivatives in babies at risk for sudden infant death syndrome should be carefully considered in each case.


Sign in / Sign up

Export Citation Format

Share Document